• Home
  • About Us
    • Our Purpose
    • Management Team
    • Investors
    • Careers
      • Current Jobs
    • Corporate Brochure
  • Our Science
    • Pipeline
    • Publications & Patents
    • TruFrag
  • Partnering
    • Collaborations
    • Licensing
    • Biotech partnering
    • Specialized services
  • News & Events
    • News
    • Events
  • Contact Us
  • Sitemap

Our Science

With about 575 scientists, Aurigene has developed

deep expertise in various target classes >>More

Trackrecord

Track-record of over 35 programs in collaboration with some of the leading global Pharma partners >>More

Our Focus

A specialized, discovery stage biotech, developing novel and best-in-class therapies to treat Oncology & Inflammation >>More

News

  • 14th Apr 2011: Debiopharm and Aurigene sign a...
  • 13th Sep 2010: Debiopharm Group™ and Aurige...
  • 9th Sep 2010: Aurigene and Pcovery in pact t...
  • 1st Sep 2009: Aurigene Announces Completion ...
  • 3rd Feb 2009: Aurigene Announced Significant...
  • 24th Nov 2008: Aurigene in licensing agreemen...
  • 25th Jun 2008: Aurigene Achieves 2nd Mileston...
  • 25th Apr 2007: Orion and Aurigene to Collabor...
  • 2nd Feb 2007: Discovery Collaborations with ...
  • 28th Jun 2006: Agreement with Debiopharm on I...
  • More news

Events

  • 18th Jun 2012: 2012 Bio International Convent...
  • 31st Mar 2012: AACR Annual Meeting 2012
  • 25th Mar 2012: 243rd ACS National Meeting �...
  • 19th Feb 2012: Tri-Con 2012
  • 5th Feb 2012: Keystone Symposia : Th17 Cells...
  • 30th Jan 2012: 4th Immunotherapeutics and Imm...
  • 9th Jan 2012: J.P. Morgan 2012 Healthcare Co...
  • 13th Dec 2011: AACR: New Horizons in Cancer R...
  • 4th Dec 2011: Natural Peptides to Drugs
  • 30th Nov 2011: CPhI India Conference 2011
  • More Events
Copyright © 2011 Aurigene Discovery Technologies.   -   All Rights Reserved